Home LiteratureArticle Details
PMID: 10375548 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Cytotoxic T lymphocyte activation by cross-priming.

Current opinion in immunology ·Vol. 11 ·No. 3 ·1999-06-00 ·Pages 314-8

Heath WR, Carbone FR

Abstract

Cross-priming represents the induction of cytotoxic T lymphocyte responses to exogenous, usually cell associated, antigens that are captured and re-presented on bone-marrow-derived antigen-presenting cells. For effective cross-priming, cytotoxic T lymphocytes require help from CD4(+) T cells, which mediate this help indirectly via modification of the antigen-presenting cell. Recent advances made in research into the cellular and molecular interactions required for cross-priming have greatly improved our understanding of the antigenic requirements for effective priming and have revealed a role for CD40 and its ligand in the provision of T cell help.

MeSH Terms
Animals Antigen Presentation Antigen-Presenting Cells/immunology CD4-Positive T-Lymphocytes/immunology CD40 Antigens/metabolism Humans Lymphocyte Activation Lymphocyte Cooperation Signal Transduction T-Lymphocytes, Cytotoxic/immunology
Chemicals
CD40 Antigens
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Heath W R
The Immunology Division, The Walter and Eliza Hall Institute of MedicalResearch, Parkville, Victoria, 3050, Australia. [email protected]
Carbone F R
Article Info
Journal
Current opinion in immunology
Abbr.
Curr Opin Immunol
ISSN
0952-7915
Published
1999-06-00
Pages
314-8
Language
English
Region
England
NLM ID
8900118
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]